Molecular targets and health benefits of cinnamon

Molecular Targets and Therapeutic Uses of Spices: Modern Uses for Ancient Medicine

Volumn , Issue , 2009, Pages 87-116

  Panickar, Kiran ^a   Cao, Heping ^a   Qin, Bolin ^a   Anderson, Richard A ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82255165006     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812837912_0004     Document Type: Chapter

References (53)

1. Dugoua JJ, Seely D, Perri D, Cooley K, Forelli T, Mills E and Koren G (2007). From type 2 diabetes to antioxidant activity: A systematic review of the safety and efficacy of common and cassia cinnamon bark. Can. J. Physiol. Pharmacol. 85: 837-847.
2. Khan A, Bryden NA, Polansky MM and Anderson RA (1990). Insulin potentiating factor and chromium content of selected foods and spices. Biol. Trace Elem. Res. 24: 183-188.
3. Broadhurst CL, Polansky MM and Anderson RA (2000). Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J. Agri. Food Chem. 48: 849-852.
4. Anderson RA and Roussel AM (2008). Cinnamon, glucose and insulin sensitivity. In: Nutraceuticals, Glycemic Health and Type 2 Diabetes (eds.) Pasupuleti V and Anderson JW. IFT Press Series, Wiley-Blackwell Publishing, pp. 127-140.
5. Duke JA (1992). Handbook of Phytomedical Constituents of GRAS Herbs and Other Economic Plants. CRC Press, Boca Raton, FL.
6. Subash BP, Prabuseenivasan S and Ignacimuthu S (2007). Cinnamaldehyde — A potential antidiabetic agent. Phytomedicine 14: 15-22.
7. Gowder SJ and Devaraj H (2006). Effect of the food flavour cinnamaldehyde on the antioxidant status of rat kidney. Basic Clin. Pharmacol. Toxicol. 99: 379-382.
8. Lee JS, Choi MS, Jeon SM, Jeong TS, Park YB, Lee MK and Bok SH (2001). Lipid-lowering and antioxidative activities of 3,4-di(OH)-cinnamate and 3,4-di(OH)-hydrocinnamate in cholesterol-fed rats. Clin. Chim. Acta 314: 221-229.
9. Martin JA, Brooks DA, Prieto L, Gonzalez R, Torrado A, Rojo I, Lopez de UB, Lamas C, Ferritto R, Dolores Martin-Ortega M, Agejas J, Parra F, Rizzo JR, Rhodes GA, Robey RL, Alt CA, Wendel SR, Zhang TY, Reifel-Miller A, Montrose-Rafizadeh C, Brozinick JT, Hawkins E, Misener EA, Briere DA, Ardecky R, Fraser JD and Warshawsky AM (2005). 2-Alkoxydihydro-cinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents. Bioorg. Med. Chem. Lett. 15: 51-55.
10. Kim SH, Hyun SH and Choung SY (2006). Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J. Ethnopharmacol. 104: 119-123.
11. Adisakwattana S, Roengsamran S, Hsu WH and Yibchok-anun S (2005). Mechanisms of antihyperglycemic effect of p-methoxycinnamic acid in normal and streptozotocin-induced diabetic rats. Life Sci. 78: 406-412.
12. Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW and Graves DJ (2004). Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J. Agri. Food Chem. 52: 65-70.
13. Cao H, Polansky MM and Anderson RA (2007). Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch. Biochem. Biophys. 459: 214-222.
14. Cao H, Urban JF, Jr. and Anderson RA (2008). Insulin increases tristetrapro-lin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes. Obesity 16: 1208-1218.
15. Cao H, Urban JF, Jr. and Anderson RA (2008). Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J. Nutr. 138: 833-840.
16. Fukuzumi M, Shinomiya H, Shimizu Y, Ohishi K and Utsumi S (1996). Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infect. Immun. 64: 108-112.
17. Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C and Pages G (2007). Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol. Biol. Cell 18: 4648-4658.
18. Ferrara N (2004). Vascular endothelial growth factor: Basic science and clinical progress. Endocr. Rev. 25: 581-611.
19. Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, Ohsugi M, Tobe K, Kadowaki T, Nagai R and Sugiura S (2007). Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56: 1517-1526.
20. Peng X, Cheng KW, Ma J, Chen B, Ho CT, Lo C, Chen F and Wang M (2008). Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J. Agri. Food Chem. 56: 1907-1911.
21. Butterfield DA, Perluigi M and Sultana R (2006). Oxidative stress in Alzheimer’s disease brain: New insights from redox proteomics. Eur. J. Pharmacol. 545: 39-50.
22. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR and de la Monte SM (2005). Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease — Is this type 3 diabetes? J. Alzheimers Dis. 7: 63-80.
23. Panickar KS and Norenberg MD (2005). Astrocytes in cerebral ischemic injury: Morphological and general considerations. Glia 50: 287-298.
24. Panickar KS, Polansky MM and Anderson RA (2007). Cinnamon polyphenols attenuate neuronal death and glial swelling in ischemic injury. Soc. Neurosci. Abs. # 380.18.
25. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y and Sato Y (2003). Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res. Clin. Pract. 62: 139-148.
26. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y and Sato Y (2004). Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm. Metab. Res. 36: 119-125.
27. Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK and Anuradha CV (2006). Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med. J. 47: 858-863.
28. Talpur N, Echard B, Ingram C, Bagchi D and Preuss H (2005). Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: A pilot study. Diabetes Obes. Metab. 7: 193-199.
29. Aybar MJ, Sanchez Riera AN, Grau A and Sanchez SS (2001). Hypoglycemic effect of the water extract of Smallantus sonchifolius (yacon) leaves in normal and diabetic rats. J. Ethnopharmacol. 74: 125-132.
30. Gomes A, Vedasiromoni JR, Das M, Sharma RM and Ganguly DK (1995). Anti-hyperglycemic effect of black tea (Camellia sinensis) in rat. J. Ethnopharmacol. 45: 223-226.
31. Lee JS, Jeon SM, Park EM, Huh TL, Kwon OS, Lee MK and Choi MS (2003). Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats. J. Med. Food 6: 183-191.
32. Khan A, Safdar M, Ali Khan MM, Khattak KN and Anderson RA (2003). Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26: 3215-3218.
33. Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP and Cokkinos DV (2005). Clinical relevance of postprandial lipaemia. Curr. Med. Chem. 12: 1931-1945.
34. Preuss HG, Echard B, Polansky MM and Anderson R (2006). Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats. J. Am. Coll. Nutr. 25: 144-150.
35. Lin CC, Wu SJ, Chang CH and Ng LT (2003). Antioxidant activity of Cinnamomum cassia. Phytother. Res. 17: 726-730.
36. Devi SL, Kannappan S and Anuradha CV (2007). Evaluation of in vitro antioxidant activity of Indian bay leaf, Cinnamomum tamala (Buch. -Ham.)T. Nees & Eberm using rat brain synaptosomes as model system. Ind. J. Exp. Biol. 45: 778-784.
37. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J and Anderson RA (2006). Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J. Int. Soc. Sports Nutr. 3: 45-53.
38. Yu Y and Lyons TJ (2005). A lethal tetrad in diabetes: Hyperglycemia, dys-lipidemia, oxidative stress, and endothelial dysfunction. Am. J. Med. Sci. 330: 227-232.
39. Robertson RP (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279: 42351-42354.
40. Osawa T and Kato Y (2005). Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann. N. Y. Acad. Sci. 1043: 440-451.
41. Roussel AM, Benaraba R, Ziegenfuss TN and Anderson RA (2008). Antioxidant effects of cinnamon extract in people with impaired fasting glucose that are overweight or obese. J. Am. Coll. Nutr. In press.
42. Hayden MR and Tyagi SC (2004). Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy. Med. Sci. Monit. 10: RA291-RA307.
43. Wang JG, Anderson RA, Graham GM, III, Chu MC, Sauer MV, Guarnaccia MM and Lobo RA (2007). The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: A pilot study. Fertil. Steril. 88: 240-243.
44. Solomon TP and Blannin AK (2007). Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes. Metab. 9: 895-901.
45. Hlebowicz J, Darwiche G, Bjorgell O and Almer LO (2007). Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am. J. Clin. Nutr. 85: 1552-1556.
46. Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK and van Loon LJ (2006). Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J. Nutr. 136: 977-980.
47. Blevins SM, Leyva MJ, Brown J, Wright J, Scofield RH and Aston CE (2007). Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Diabetes Care 30: 2236-2237.
48. Altschuler JA, Casella SJ, MacKenzie TA and Curtis KM (2007). The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care 30: 813-816.
49. Baker WL, Gutierrez-Williams G, White CM, Kluger J and Coleman CI (2008). Effect of cinnamon on glucose control and lipid parameters. Diabetes Care 31: 41-43.
50. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO and Hahn A (2006). Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur. J. Clin. Invest. 36: 340-344.
51. Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebritsen TS, Anderson RA and Graves DJ (1998). Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: Implications for cinnamon regulation of insulin signalling. Horm. Res. 50: 177-182.
52. Jarvill-Taylor KJ, Anderson RA and Graves DJ (2001). A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J. Am. Coll. Nutr. 20: 327-336.
53. Suppapitiporn S, Kanpaksi N and Suppapitiporn S (2006). The effect of cinnamon cassia powder in type 2 diabetes mellitus. J. Med. Assoc. Thai. (Suppl.) 89(3): S200-S205.